Snowball logo
logo
7QD

CLOVER HEALTH INV. CL.A

€4.03-€0.06  (1.47%)
Estimate
EPS
-0.04
Beta
2.463
Growth
Revenue, YoY
59.76%
Net income, YoY
371.79%
FCF, YoY
419.97%
About the company
Ticker
7QD
ISIN
US18914F1030
Country
United States of America
Sector (GICS)
Healthcare
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.

Frequently asked questions

What sector does CLOVER HEALTH INV. CL.A (7QD) operate in?

CLOVER HEALTH INV. CL.A belongs to the Healthcare sector and operates in the Healthcare Plans industry.

What is CLOVER HEALTH INV. CL.A (7QD) current stock price?

As of the latest data, CLOVER HEALTH INV. CL.A stock price is €4.03, with a previous close of €4.09. CLOVER HEALTH INV. CL.A lost -€0.06 in the last trading session, representing a -1.47% loss.

What is CLOVER HEALTH INV. CL.A (7QD) current market capitalization?

CLOVER HEALTH INV. CL.A market cap is approximately 1.75 billion.

What is CLOVER HEALTH INV. CL.A (7QD) Earnings Per Share (EPS)?

The trailing EPS is -€0.04.

What is CLOVER HEALTH INV. CL.A (7QD) EBITDA?

CLOVER HEALTH INV. CL.A EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 25.01 million.

Does CLOVER HEALTH INV. CL.A (7QD) pay dividends?

No. CLOVER HEALTH INV. CL.A does not pay a dividend.

When is CLOVER HEALTH INV. CL.A (7QD) next earnings report?

CLOVER HEALTH INV. CL.A is expected to release its next earnings report on September 30, 2026.

What is CLOVER HEALTH INV. CL.A (7QD) beta (volatility) score?

CLOVER HEALTH INV. CL.A has a beta of 2.463, indicating very high volatility compared to the market.